Novo Sues Viatris to Block Copies of Another Weight-Loss Drug – Bloomberg Law News

Novo Nordisk A/S expanded its courtroom fight to protect its obesity drugs segment, alleging that a copy of Wegovy proposed by Viatris Inc.